INVESTIGATION ALERT: Halper Sadeh LLP Investigates RFL, VNE, ACBI, KIN; Shareholders are Encouraged to Contact the Firm
If you are a Holdings shareholder, click here to learn more about your rights and options .
NEW YORK, July 29, 2021 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:
Rafael Holdings, Inc. (NYSE: RFL) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its merger with Rafael Pharmaceuticals, Inc. (“Pharma”). In connection with the proposed merger, Pharma shareholders will receive Holdings Class B common stock amounting to approximately 48% of the currently outstanding capitalization of the company. Additional equity in the company is expected to be issued in connection with anticipated financing and employment agreements, which will reduce the foregoing percentage proportionately. If you are a Holdings shareholder, click here to learn more about your rights and options.
Veoneer, Inc. (NYSE: VNE) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Magna International Inc. for $31.25 per share in cash. If you are a Veoneer shareholder, click here to learn more about your rights and options.
Atlantic Capital Bancshares, Inc. (NASDAQ: ACBI) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to SouthState Corporation. Subject to the terms of the merger agreement, Atlantic Capital shareholders will receive 0.36 shares of SouthState common stock for each outstanding share of Atlantic Capital common stock. If you are an Atlantic Capital shareholder, click here to learn more about your rights and options.
Kindred Biosciences, Inc. (NASDAQ: KIN) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Elanco Animal Health Incorporated for $9.25 per share. If you are a Kindred Biosciences shareholder, click here to learn more about your rights and options.
Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options. Please call Daniel Sadeh or Zachary Halper at (212) 763-0060 or email [email protected] or [email protected].
Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLP
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com
